Rapid solutions at the Point-of-CareWhen timing is Critical, so is the Result.

Cardiac BiomarkersBlood Gas, Glucose, Electrolytes & MetabolitesToxicologyRespiratory Infections

epoc® Blood Analysis System.Lab quality, wireless results in about 30 seconds with full test menu on a single room temperature test card.1

Immediate access to critical resultsaccelerates clinical decisions andtherapeutic intervention

• Reduce or eliminate sample transport and labeling errors

• Integrated barcode scanner reduces data entry errors

• Automated, integrated calibration and quality checks

• Significantly reduce test-to-decision time vs. traditional lab testing

• Easy to use at the patient bedside

• Designed to be cost effective

Store test cards at room temperatureat the bedside

• Blood gases: pH, pCO2, pO2

• Electrolytes: Na+, K+, Ca++

• Metabolites: Glu, Lac

• Hematocrit

• Calculated analytes: HCO3-, TCO2, Base Excess, cSO2, cHgb

• Creatinine and Chloride coming soon

• Test Cards are barcoded for improved quality and inventory management

Increase staff efficiency and reduce errors with Wireless Connectivity

• Wireless data capture and LIS/HIS Connectivity via HL7 standard

• Web-based epoc® Enterprise Data Manager (EDM) software accessible via any networked computer

• PC-based EDM-Lite coming soon

Test Blood Gas, Glucose, Lactate, Electrolytes and Metabolites at the bedside

Alere Triage® - the Point of Care systemfor rapid, accurate results

Choose the panel(s) that match your requirementsAvailable test

panelsTrop BNP CKMB D-dimer NT-proBNP NGAL PLGF TOX Drug

Screen

Troponin I X

BNP X

Cardio 2 X X

Cardio 3 X X X

D-dimer X

NT-proBNP X

NGAL X

PLGF X

TOX Drug Screen X

• Results in approximately 15 - 20 minutes

• Controls built into the meter, software and test panel

• Several QC lockouts including unauthorised users

• Connectivity options including interface with your Laboratory Information System

Take advantage of oureasy Alere Triage®

acquisition program.

The Alere Triage® System is a leading novel, rapid diagnostic test system that improves a physician’s ability to aid in the diagnosisof critical diseases and health conditions.

Rapidly detect infection and improve patient outcomes

Rapid, cost-effective, diagnostic options can help identify the cause of infection earlier, allowing timely treatment decisions.

Alere BinaxNOW® RSV

Rapid identification of Respiratory Syncytial Virus (RSV) with a simple one-step method using a nasal sample. This allows immediate treatment to be initiated and limits the spread of infection.

• Helps save costs by reducing hospital stays and the use of antimicrobials

• Guides timely, appropriate therapy

• Results in 15 minutes

Alere BinaxNOW® Influenza

Rapid identification of Influenza A or B in one simple test using a nasal sample (or use the same sample used for RSV) to enable rapid initiation of antiviral treatment, and limit the spread of infection.

• Objective, easy to interpret results

• Decrease unnecessary antibiotic use

• Results in 15 minutes

Alere BinaxNOW® S. pneumoniae

Rapid diagnosis of pneumococcal pneumonia and pneumococcal meningitis.

• Enables targeted narrow spectrum antibiotics

• Advocated by Worldwide Community Acquired Pneumonia Guidelines

• Results in 15 minutes

Alere BinaxNOW® Legionella

Rapid identification of Legionella with easy-to-use technology, aiding physicians in providing rapid, focused therapy.

• Reduces high mortality rate associated with disease2

• Advocated by Worldwide Community Acquired Pneumonia Guidelines

• Results in 15 minutes

Visit TestTargetTreat.comTESTTARGETTREAT TM

Simplify your drug screening process withAlere Triage® TOX Drug Screen

When choosing a rapid drug screen, there are many factors toconsider: accuracy, ease-of-use, system interface capabilitiesand test selectivity. Compare the Alere Triage® TOX Drug Screen with other drug screening options:

ProductOfferings

Alere Triage® TOXDrug Screen

Large PlatformChemistryAnalyser

Lateral FlowVisual Read

Lateral Flow w/Scanner/Reader

Point-of-Care p NO p NO

Test Selectivity p p NO NO

OperatorLock Out

p p NO NO

QC Lock Out p p NO NO

QC Frequency Monthly Daily Daily to Monthly Weekly

US Interface p p NO p

AcetaminophenTesting

p p NO NO

Technology Spectrophotometer Spectrophotometer Visual:Line/No Line

Scanner

Methodology Automated, calibratedimmunoassay(Fluorescence)

Automated, calibratedimmunoassay

(Enzyme fluorescence or micro-particle)

Manual processVisual read

Manual processScanner read

Know quickly with confidence Rapidly identifying or ruling out the impact of drug use on the patient’s clinical presentation can help reduce their length of stay in the emergency department.

Features & Benefits

• Built-in QC satisfies daily QC; external POS/NEG QC run once per month*

• Patient sample is automatically analysed against the lot specific calibration curve provided via the CODE CHIP™

• Qualitative POS/NEG results are displayed, printed and can be transmitted.

• Alere Triage® MeterPro connects to your Laboratory Information System (LIS).

*or once per new lot or shipment

Alere Triage® TOX Drug Screen assay menu:

APAP AcetaminophenAMP AmphetaminesmAMP MethamphetaminesBAR BarbituratesBZO BenzodiazepinesCOC CocaineMTD MethadoneOPI OpiatesPCP PhencyclidineTHC Tetrahydrocannabinol (Cannabis)TCA Tricyclic Antidepressants

Clinical Presentation Importance of Drug Detection

Acute Liver Failure Acetaminophen overdose is the most commoncause of acute liver failure and is often asymptomatic.

Altered Mental Status/ Psychosis

Rule out drugs as cause; clear patient for psychiatricevaluation and placement.

Chest Pain Avoid the use of beta-blockers for cocaine associatedchest pain.

Coma Rule out drugs as cause or determine appropriatetreatment.

Major Trauma Mind-altering substances may mask a patient’s painlevel causing injuries to go undetected.

Possible Overdose Provide appropriate treatment and antidote if needed.

Respiratory Depression Symptomatic of drug overdose; rule in/rule out drugsas a cause.

Seizure Rule in/out drugs as cause; overdose, withdrawal orother medical conditions.

Ordering InformationProduct Name Product No. Qty

epoc® epoc® Host2 with Barcode Scanner EA-HH-1009 1

epoc® Reader EA-HR-1002 1

epoc® BGEM Test Card EA-CT-1004 50

Eurotrol GAS-ISE Metabol Control Lvl 1 EA-179.001.010 10

Eurotrol GAS-ISE Metabol Control Lvl 3 EA-179.003.010 10

Eurotrol Hct Control, Lvl A EA-195.002.010 10

Eurotrol Hct Control, Lvl B EA-195.004.010 10

Zebra MZ320 w BT (Printer) EA-MZ-320 1

Zebra Printer Paper EA-MZ-320 Paper 1

epoc® Link EA-TEW-654TR 1

epoc® Electronic Data Management EA-SD-0001 1

epoc Customer Care Plan epoc-ACCP 1

Triage® Triage® Troponin I BS98600EU 25

Triage® BNP BS98000XREU 25

Triage® NT-proBNP BS98700EU 25

Cardio 2 BS97500EU 25

Cardio 3 BS97400EU 25

Triage® D-Dimer BS98100EU 25

Triage® NGAL BS98400EU 25

Triage® PLGF 98800EU 25

Triage® TOX Screen BS94400EU 25

BinaxNOW® BinaxNOW® Influenza BN416-000 22

BinaxNOW® RSV BN430-000BN430-012

4222

BinaxNOW® S.pneumoniae BN710-000BN710-012

2212

BinaxNOW® Legionella BN852-000BN852-012

2212

To find out more visit alere.com.au

Australia

New Zealand

au.enquiries@alere.com

nz.enquiries@alere.com

1800 622 642 Free call in AUS

0800 466 951 Free call in NZ

alere.com.au

alere.co.nz

For more information or for full instructions for the products listed in this brochure, please refer to the product package insert.Please note that not all products are available in all markets.

References:1 Evaluation of the epoc Blood Gas and Electrolyte Point of Care Instrument, AACB Sydney, October 20112 Alvarez et al. Impact of the Legionella urinary antigen test on epidemiological trends in community outbreaks of legionellosis in Catalonia, Spain, 1990-2004. International Journal of Infectious Diseases (2009) 13, e365-e370

©2013 Alere. All rights reserved. The Alere Logo, Alere, epoc, Triage, and BinaxNOW are trademarks of the Alere group of companies. A1767